{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:46:24Z","timestamp":1793303184633,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1245\/s10434-022-12064-4","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T07:03:39Z","timestamp":1657782219000},"page":"7769-7778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer"],"prefix":"10.1245","volume":"29","author":[{"given":"Stacy B.","family":"Sanders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya L.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle P.","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-3228","authenticated-orcid":false,"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"issue":"3","key":"12064_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","volume":"88","author":"LE Warren","year":"2014","unstructured":"Warren LE, Miller CL, Horick N, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014;88(3):565\u201371.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"10","key":"12064_CR2","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1245\/s10434-017-5960-x","volume":"24","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol. 2017;24(10):2972\u201380.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"12064_CR3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamasurg.2019.1742","volume":"154","author":"JM Armer","year":"2019","unstructured":"Armer JM, Ballman KV, McCall L, et al. Factors associated with lymphedema in women with node-positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection. JAMA Surg. 2019;154(9):800\u20139.","journal-title":"JAMA Surg."},{"issue":"9","key":"12064_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/bjs.9846","volume":"102","author":"M Cariati","year":"2015","unstructured":"Cariati M, Bains SK, Grootendorst MR, et al. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema. Br J Surg. 2015;102(9):1071\u20138.","journal-title":"Br J Surg."},{"issue":"35","key":"12064_CR5","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1200\/JCO.2008.16.4731","volume":"26","author":"RL Ahmed","year":"2008","unstructured":"Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women\u2019s Health Study. J Clin Oncol. 2008;26(35):5689\u201396.","journal-title":"J Clin Oncol."},{"issue":"21","key":"12064_CR6","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1200\/JCO.2007.14.4899","volume":"26","author":"SC Hayes","year":"2008","unstructured":"Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536\u201342.","journal-title":"J Clin Oncol."},{"issue":"11","key":"12064_CR7","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/bjs.11617","volume":"107","author":"JL Morgan","year":"2020","unstructured":"Morgan JL, George J, Holmes G, et al. Breast cancer surgery in older women: outcomes of the Bridging Age Gap in Breast Cancer study. Br J Surg. 2020;107(11):1468\u201379.","journal-title":"Br J Surg."},{"issue":"8","key":"12064_CR8","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1245\/s10434-018-6531-5","volume":"25","author":"BL Murphy","year":"2018","unstructured":"Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC. Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: Triple-negative and HER2+ subtypes. Ann Surg Oncol. 2018;25(8):2241\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"14","key":"12064_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361.","journal-title":"JAMA."},{"issue":"7","key":"12064_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318.","journal-title":"Lancet Oncol."},{"issue":"3","key":"12064_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"J-F Boileau","year":"2015","unstructured":"Boileau J-F, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201364.","journal-title":"J Clin Oncol."},{"issue":"2","key":"12064_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","volume":"173","author":"J-M Classe","year":"2019","unstructured":"Classe J-M, Loaec C, Gimbergues P, et al. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat. 2019;173(2):343\u201352.","journal-title":"Breast Cancer Res Treat."},{"issue":"10","key":"12064_CR13","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1245\/s10434-019-07540-3","volume":"26","author":"MK Srour","year":"2019","unstructured":"Srour MK, Tseng J, Luu M, Alban RF, Giuliano AE, Chung A. Patterns in the use of axillary operations for patients with node-positive breast cancer after neoadjuvant chemotherapy: a National Cancer Database (NCDB) analysis. Ann Surg Oncol. 2019;26(10):3305\u201311.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"12064_CR14","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1245\/s10434-018-6637-9","volume":"25","author":"TT Nguyen","year":"2018","unstructured":"Nguyen TT, Hoskin TL, Day CN, et al. Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol. 2018;25(9):2596\u2013602.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"12064_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ejso.2019.01.219","volume":"45","author":"R Di Micco","year":"2019","unstructured":"Di Micco R, Zuber V, Fiacco E, et al. Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: time trend, imaging staging power and nodal downstaging according to molecular subtype. Eur J Surg Oncol. 2019;45(6):969\u201375.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"12064_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-020-05589-3","volume":"180","author":"JM Simons","year":"2020","unstructured":"Simons JM, Koppert LB, Luiten EJT, et al. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study. Breast Cancer Res Treat. 2020;180(3):725\u201333.","journal-title":"Breast Cancer Res Treat."},{"issue":"12","key":"12064_CR17","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1245\/s10434-020-08900-0","volume":"27","author":"MA Piltin","year":"2020","unstructured":"Piltin MA, Hoskin TL, Day CN, Davis J, Boughey JC. Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer. Ann Surg Oncol. 2020;27(12):4795\u2013801.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"12064_CR18","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1245\/s10434-019-07583-6","volume":"26","author":"SM Wong","year":"2019","unstructured":"Wong SM, Weiss A, Mittendorf EA, King TA, Golshan M. Surgical management of the axilla in clinically node-positive patients receiving neoadjuvant chemotherapy: a National Cancer Database analysis. Ann Surg Oncol. 2019;26(11):3517\u201325.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"12064_CR19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol."},{"issue":"3","key":"12064_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426\u201332; discussion 432\u201333.","journal-title":"Ann Surg."},{"issue":"4","key":"12064_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297\u2013305.","journal-title":"Lancet Oncol."},{"issue":"4","key":"12064_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"A Savolt","year":"2017","unstructured":"Savolt A, Peley G, Polgar C, et al. Eight-year follow up result of the OTOASOR Trial: the Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017;43(4):672\u20139.","journal-title":"Eur J Surg Oncol."},{"issue":"12","key":"12064_CR23","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1002\/cncr.23481","volume":"112","author":"JS Jeruss","year":"2008","unstructured":"Jeruss JS, Newman LA, Ayers GD, et al. Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer. 2008;112(12):2646\u201354.","journal-title":"Cancer."},{"issue":"7","key":"12064_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.clbc.2017.03.014","volume":"17","author":"JM Ryu","year":"2017","unstructured":"Ryu JM, Lee SK, Kim JY, et al. Predictive factors for nonsentinel lymph node metastasis in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy: nomogram for predicting nonsentinel lymph node metastasis. Clin Breast Cancer. 2017;17(7):550\u20138.","journal-title":"Clin Breast Cancer."},{"issue":"6","key":"12064_CR25","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1245\/s10434-018-6429-2","volume":"25","author":"T-A Moo","year":"2018","unstructured":"Moo T-A, Edelweiss M, Hajiyeva S, et al. Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection? Ann Surg Oncol. 2018;25(6):1488\u201394.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"12064_CR26","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1245\/s10434-018-6578-3","volume":"25","author":"AU Barron","year":"2018","unstructured":"Barron AU, Hoskin TL, Boughey JC. Predicting non-sentinel lymph node metastases in patients with a positive sentinel lymph node after neoadjuvant chemotherapy. Ann Surg Oncol. 2018;25(10):2867\u201374.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"12064_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10147-012-0418-4","volume":"18","author":"H Takei","year":"2013","unstructured":"Takei H, Yoshida T, Kurosumi M, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation. Int J Clin Oncol. 2013;18(3):547\u201353.","journal-title":"Int J Clin Oncol."},{"issue":"3","key":"12064_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jso.25989","volume":"122","author":"M Cheng","year":"2020","unstructured":"Cheng M, Zhuang X, Zhang L, et al. A nomogram to predict non-sentinel lymph node metastasis in patients with initial cN+ breast cancer that downstages to cN0 after neoadjuvant chemotherapy. J Surg Oncol. 2020;122(3):373\u201381.","journal-title":"J Surg Oncol."},{"key":"12064_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.radonc.2021.08.013","volume":"163","author":"MC Leonardi","year":"2021","unstructured":"Leonardi MC, Arrobbio C, Gandini S, et al. Predictors of positive axillary non-sentinel lymph nodes in breast cancer patients with positive sentinel lymph node biopsy after neoadjuvant systemic therapy. Radiother Oncol. 2021;163:128\u201335.","journal-title":"Radiother Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12064-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12064-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12064-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T22:13:57Z","timestamp":1665440037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12064-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["12064"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12064-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stacy B. Sanders, Tanya L. Hoskin, Arielle P. Stafford, and Judy C. Boughey have no conflicts of interest or sources of funding to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}